Delivery Order SPE2DB20D2014-SPE2DB24FC74V
Award Date
8/13/24
Potential Completion Date
8/14/24
Potential Value
$7.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of RINVOQ ER 15 MG TABLET. The order is valued at $3,049.95 and has a completion date of July 19, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several indefinite-delivery contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a comprehensive range of medical commodities. This delivery order is likely part...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of RINVOQ ER 15 MG TABLET. The contract has a ceiling value of $13,696.55 and a period of performance through August 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical for delivering a comprehensive range of medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a medication, with a ceiling value of $7,988.97 and a period of performance through July 2, 2025. This delivery order is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the prescription medication RINVOQ ER 15 MG TABLET. The contract has a firm fixed price of $3,137.01 and an ultimate completion date of April 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,156.58 firm-fixed-price contract is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a prescription medication. It has an ultimate completion date of November 14, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,775.82, is for the supply of RINVOQ ER 15 MG TABLET to support federal healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 15 mg tablets. The firm-fixed-price contract, valued at $8,523.61, has an ultimate completion date of September 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 45 MG TABLET UU 28S. The award, valued at $47,941.34, has a completion date of September 19, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of...
This is a $10,288.68 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 45 mg RINVOQ ER tablets. The order has a completion date of June 27, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and government healthcare programs...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,566,093,132 units of the pharmaceutical product RINVOQ ER 15 MG TABLET. The contract has a ceiling value of $23,977.29 and a period of performance through October 15, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support military treatment facilities and other federal healthcare programs....